United Therapeutics | UTHR - Current Assets


United Therapeutics reported $3.49B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Amarin USD 628.33M 21.52M Sep/2025
Ardelyx USD 367.98M 16.42M Sep/2025
Baxter International USD 6.93B 184M Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Biogen USD 8.94B 968.9M Sep/2025
BioMarin Pharmaceutical USD 3.85B 49.21M Sep/2025
Gilead Sciences USD 18.84B 4.12B Sep/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Insmed USD 1.93B 149.77M Sep/2025
Ionis Pharmaceuticals USD 2.52B 58.16M Sep/2025
J&J USD 54.61B 113M Sep/2025
Moderna USD 6.6B 427M Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
PTC Therapeutics USD 2.01B 265.07M Sep/2025
Regeneron Pharmaceuticals USD 17.98B 1.12B Sep/2025
Sarepta Therapeutics USD 2.72B 65.32M Sep/2025
Teva Pharmaceutical Industries USD 13.95B 1.21B Dec/2025
United Therapeutics USD 3.49B 332.9M Sep/2025
Vertex Pharmaceuticals USD 10.57B 141.7M Sep/2025